255 related articles for article (PubMed ID: 28577132)
1. Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.
Yang JS; Wu XH; Yu HG; Teng LS
Inflammopharmacology; 2017 Aug; 25(4):471-484. PubMed ID: 28577132
[TBL] [Abstract][Full Text] [Related]
2. Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model.
Hsieh MH; Gu SL; Ho SC; Pawlak CR; Lin CL; Ho YJ; Lai TJ; Wu FY
Behav Brain Res; 2012 Apr; 229(1):41-7. PubMed ID: 22227506
[TBL] [Abstract][Full Text] [Related]
3. Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.
Ho YJ; Ho SC; Pawlak CR; Yeh KY
Behav Brain Res; 2011 Jun; 219(2):280-90. PubMed ID: 21262271
[TBL] [Abstract][Full Text] [Related]
4. Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.
Ho SC; Hsu CC; Pawlak CR; Tikhonova MA; Lai TJ; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2014 Jul; 268():177-84. PubMed ID: 24755306
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia.
Hsieh MH; Meng WY; Liao WC; Weng JC; Li HH; Su HL; Lin CL; Hung CS; Ho YJ
Brain Res Bull; 2017 Jun; 132():129-138. PubMed ID: 28576659
[TBL] [Abstract][Full Text] [Related]
6. Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model.
Hsieh MH; Ho SC; Yeh KY; Pawlak CR; Chang HM; Ho YJ; Lai TJ; Wu FY
Pharmacol Biochem Behav; 2012 Jul; 102(1):64-71. PubMed ID: 22487770
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Hsu CY; Hung CS; Chang HM; Liao WC; Ho SC; Ho YJ
Neuropharmacology; 2015 Apr; 91():43-56. PubMed ID: 25499022
[TBL] [Abstract][Full Text] [Related]
8. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus.
Sy HN; Wu SL; Wang WF; Chen CH; Huang YT; Liou YM; Chiou CS; Pawlak CR; Ho YJ
Pharmacol Biochem Behav; 2010 Apr; 95(2):158-65. PubMed ID: 20064549
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease.
Kumar P; Kaundal RK; More S; Sharma SS
Behav Brain Res; 2009 Feb; 197(2):398-403. PubMed ID: 18983875
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
Castro AA; Wiemes BP; Matheus FC; Lapa FR; Viola GG; Santos AR; Tasca CI; Prediger RD
Brain Res; 2013 Jun; 1513():103-16. PubMed ID: 23548600
[TBL] [Abstract][Full Text] [Related]
11. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
12. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats.
Wang AL; Liou YM; Pawlak CR; Ho YJ
Behav Brain Res; 2010 Mar; 208(1):38-46. PubMed ID: 19900486
[TBL] [Abstract][Full Text] [Related]
14. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
Ding W; Lin H; Hong X; Ji D; Wu F
Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
[TBL] [Abstract][Full Text] [Related]
15. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
16. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.
Wu J; Zhao YM; Deng ZK
Inflammopharmacology; 2018 Feb; 26(1):119-132. PubMed ID: 28871498
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Huang CK; Chang YT; Amstislavskaya TG; Tikhonova MA; Lin CL; Hung CS; Lai TJ; Ho YJ
Behav Brain Res; 2015 Nov; 294():198-207. PubMed ID: 26296668
[TBL] [Abstract][Full Text] [Related]
18. Measuring attention in a Parkinson's disease rat model using the 5-arm maze test.
Ho SC; Hsu CC; Yu CH; Huang WN; Tikhonova MA; Ho MC; Hung CS; Amstislavskaya TG; Ho YJ
Physiol Behav; 2014 May; 130():176-81. PubMed ID: 24690450
[TBL] [Abstract][Full Text] [Related]
19. Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model.
Ling L; Jiang Y; Liu Y; Li H; Bari A; Ullah R; Xue J
J Photochem Photobiol B; 2019 Dec; 201():111657. PubMed ID: 31706085
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
